The Challenges And Opportunities Of Virtual Clinical Trials

Virtual Trials, also known as Decentralized Clinical Trials or Siteless Trials, revolutionize the traditional clinical trial model by enabling participants to engage from the comfort of their homes through a centralized virtual hub. Key components such as the Investigational Product and wearables are conveniently dispatched to participants, while study physicians and pharmacists provide remote support via video conferencing. The gathering of medical data is facilitated through mobile health applications and telehealth technologies, which transmit this information to the central study center.

The surge in popularity of Virtual Clinical Trials emerged in response to the challenges posed by the COVID-19 pandemic, prompting various industries, including the medical and research sectors, to adapt and devise contingency plans. With ongoing technological advancements, consider several factors as to why experts believe that, despite its unique set of challenges, Virtual Clinical Trials will continue to play a significant role even beyond the post-pandemic era.